Delivery Order SPE2DB22D2206-SPE2DB24FGA16
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,543.50, is a delivery order for 4560629302 - NAFTIFINE HCL 2% CREAM 45GM. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,210.56 firm fixed-price delivery order contract is for the supply of NAFTIFINE HCL 2% CREAM 60GM, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of April 2, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Naftifine HCL 2% cream in 60-gram units. The $2,697.07 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on May 31, 2024, with a completion date of June 3, 2024. This order is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award, valued at $1,961.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naftifine HCL 2% Cream 60GM. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Naftifine HCL 1% Cream 60GM to the Defense Logistics Agency (DLA). The Delivery Order contract, valued at $1,588.18, has a firm fixed price and runs through January 4, 2024. The contract was awarded on January 3, 2024, and there is no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,873.54 for the supply of 4556611118 - Naftifine HCL 1% Cream 60GM. The contract has an ultimate completion date of March 21, 2022 and was awarded on March 18, 2022 under a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NAFTIFINE HCL 2% GEL 60GM. The contract has a ceiling value of $15,068.59 and a period of performance through April 8, 2024. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $1,889.68 award is for the supply of 4564249290 - NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The order has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $4,737.94 for the supply of NAFTIFINE HCL 1% CREAM 60GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract type is Firm Fixed Price, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, with ID SPE2DB20D3104|SPE2DB25FV6N5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,710.45 Firm Fixed Price Delivery Order contract is for the supply of 4567944105 - NAFTIFINE HCL 2% CREAM 45GM, with a performance period ending on April 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGA16Delivery Order
This federal contract award is for the delivery of NAFTIFINE HCL 2% CREAM 60GM to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $2,564.44 and a performance period through March 11, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The current award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 3/9/24 |